A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis ...

Background and objectives Shenqi Fuzheng (SQ) is a widely used Chinese medicine formula known for its immune-enhancing and Qi ...

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive agreement for the clinical-stage ...

The company plans to leverage research and development incentives from the Australian Government to offset the trial costs.

For both the SAD and MAD portions of the trial, pharmacodynamic markers, including pSTAT levels, were measured.

Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...

Wells Fargo raised the firm’s price target on Rapt Therapeutics (RAPT) to $6 from $4 and keeps an Overweight rating on the shares. With the ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has ...

To design safe and effective drugs, the pharmacology of how drugs work in relationship to the body must be understood. This ...

GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...

Shenqi Fuzheng (SQ) is a widely used Chinese medicine formula known for its immune-enhancing and Qi-supplementing properties. However, the ...

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of ...